A detailed history of Gm Advisory Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Gm Advisory Group, Inc. holds 4,863 shares of ABT stock, worth $497,630. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,863
Previous 4,823 0.83%
Holding current value
$497,630
Previous $530,000 4.15%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$109.52 - $120.96 $4,380 - $4,838
40 Added 0.83%
4,863 $552,000
Q4 2023

Feb 12, 2024

SELL
$90.19 - $110.4 $7,575 - $9,273
-84 Reduced 1.71%
4,823 $530,000
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $1,719 - $2,063
18 Added 0.37%
4,907 $475,000
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $492,713 - $548,985
4,889 New
4,889 $532,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Gm Advisory Group, Inc. Portfolio

Follow Gm Advisory Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gm Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gm Advisory Group, Inc. with notifications on news.